335 related articles for article (PubMed ID: 34130124)
1. Peroxiredomin-4 ameliorates lipotoxicity-induced oxidative stress and apoptosis in diabetic cardiomyopathy.
Zhang B; Li X; Liu G; Zhang C; Zhang X; Shen Q; Sun G; Sun X
Biomed Pharmacother; 2021 Sep; 141():111780. PubMed ID: 34130124
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rb1 ameliorates lipotoxicity-induced myocardial injury in diabetes mellitus by regulating Mfn2.
Ji L; Han H; Shan X; Zhao P; Chen H; Zhang C; Xu M; Lu R; Guo W
Eur J Pharmacol; 2024 Jul; 974():176609. PubMed ID: 38677536
[TBL] [Abstract][Full Text] [Related]
3. New mechanism of lipotoxicity in diabetic cardiomyopathy: Deficiency of Endogenous H
Guo R; Wu Z; Jiang J; Liu C; Wu B; Li X; Li T; Mo H; He S; Li S; Yan H; Huang R; You Q; Wu K
Mech Ageing Dev; 2017 Mar; 162():46-52. PubMed ID: 27871808
[TBL] [Abstract][Full Text] [Related]
4. GCN2 deficiency ameliorates cardiac dysfunction in diabetic mice by reducing lipotoxicity and oxidative stress.
Feng W; Lei T; Wang Y; Feng R; Yuan J; Shen X; Wu Y; Gao J; Ding W; Lu Z
Free Radic Biol Med; 2019 Jan; 130():128-139. PubMed ID: 30389499
[TBL] [Abstract][Full Text] [Related]
5. Ophiopogonin D alleviates diabetic myocardial injuries by regulating mitochondrial dynamics.
Li W; Ji L; Tian J; Tang W; Shan X; Zhao P; Chen H; Zhang C; Xu M; Lu R; Guo W
J Ethnopharmacol; 2021 May; 271():113853. PubMed ID: 33485986
[TBL] [Abstract][Full Text] [Related]
6. Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress.
Gu X; Shi Y; Chen X; Sun Z; Luo W; Hu X; Jin G; You S; Qian Y; Wu W; Liang G; Wu G; Chen Z; Chen X
Phytomedicine; 2020 Nov; 78():153319. PubMed ID: 32950951
[TBL] [Abstract][Full Text] [Related]
7. Beneficial Effects of Echinacoside on Diabetic Cardiomyopathy in Diabetic
Zhang X; Hao Y
Drug Des Devel Ther; 2020; 14():5575-5587. PubMed ID: 33376302
[TBL] [Abstract][Full Text] [Related]
8. Astragalus polysaccharides inhibits cardiomyocyte apoptosis during diabetic cardiomyopathy via the endoplasmic reticulum stress pathway.
Sun S; Yang S; An N; Wang G; Xu Q; Liu J; Mao Y
J Ethnopharmacol; 2019 Jun; 238():111857. PubMed ID: 30959142
[TBL] [Abstract][Full Text] [Related]
9. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats.
Luo J; Yan D; Li S; Liu S; Zeng F; Cheung CW; Liu H; Irwin MG; Huang H; Xia Z
J Cell Mol Med; 2020 Jan; 24(2):1760-1773. PubMed ID: 31856386
[TBL] [Abstract][Full Text] [Related]
10. MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα.
Yin Z; Zhao Y; He M; Li H; Fan J; Nie X; Yan M; Chen C; Wang DW
Cardiovasc Diabetol; 2019 Jan; 18(1):7. PubMed ID: 30635067
[TBL] [Abstract][Full Text] [Related]
11. SIRT6‑specific inhibitor OSS‑128167 exacerbates diabetic cardiomyopathy by aggravating inflammation and oxidative stress.
Huang Y; Zhang J; Xu D; Peng Y; Jin Y; Zhang L
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760202
[TBL] [Abstract][Full Text] [Related]
12. Mst1 knockdown alleviates cardiac lipotoxicity and inhibits the development of diabetic cardiomyopathy in db/db mice.
Xiong Z; Li Y; Zhao Z; Zhang Y; Man W; Lin J; Dong Y; Liu L; Wang B; Wang H; Guo B; Li C; Li F; Wang H; Sun D
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165806. PubMed ID: 32320827
[TBL] [Abstract][Full Text] [Related]
13. Macrod1 suppresses diabetic cardiomyopathy via regulating PARP1-NAD
Liu YT; Qiu HL; Xia HX; Feng YZ; Deng JY; Yuan Y; Ke D; Zhou H; Che Y; Tang QZ
Acta Pharmacol Sin; 2024 Jun; 45(6):1175-1188. PubMed ID: 38459256
[TBL] [Abstract][Full Text] [Related]
14. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
[TBL] [Abstract][Full Text] [Related]
15. Guan Xin Dan Shen formulation protects
Zhang B; Zhang CY; Zhang XL; Sun GB; Sun XB
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036388
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
[TBL] [Abstract][Full Text] [Related]
17. Activation of nuclear β-catenin/c-Myc axis promotes oxidative stress injury in streptozotocin-induced diabetic cardiomyopathy.
Liu P; Su J; Song X; Wang S
Biochem Biophys Res Commun; 2017 Dec; 493(4):1573-1580. PubMed ID: 28989026
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-33 alleviates diabetic cardiomyopathy through regulation of endoplasmic reticulum stress and autophagy via insulin-like growth factor-binding protein 3.
Wu MX; Wang SH; Xie Y; Chen ZT; Guo Q; Yuan WL; Guan C; Xu CZ; Huang YN; Wang JF; Zhang HF; Chen YX
J Cell Physiol; 2021 Jun; 236(6):4403-4419. PubMed ID: 33184863
[TBL] [Abstract][Full Text] [Related]
20. Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats.
Diao J; Wei J; Yan R; Fan G; Lin L; Chen M
J Physiol Biochem; 2019 Feb; 75(1):39-51. PubMed ID: 30225723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
